Correlation Between Caribou Biosciences and Dynavax Technologies
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Dynavax Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Dynavax Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Dynavax Technologies, you can compare the effects of market volatilities on Caribou Biosciences and Dynavax Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Dynavax Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Dynavax Technologies.
Diversification Opportunities for Caribou Biosciences and Dynavax Technologies
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Caribou and Dynavax is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Dynavax Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dynavax Technologies and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Dynavax Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dynavax Technologies has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Dynavax Technologies go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Dynavax Technologies
Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Dynavax Technologies. In addition to that, Caribou Biosciences is 5.6 times more volatile than Dynavax Technologies. It trades about -0.1 of its total potential returns per unit of risk. Dynavax Technologies is currently generating about 0.13 per unit of volatility. If you would invest 1,249 in Dynavax Technologies on September 25, 2024 and sell it today you would earn a total of 29.00 from holding Dynavax Technologies or generate 2.32% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 95.24% |
Values | Daily Returns |
Caribou Biosciences vs. Dynavax Technologies
Performance |
Timeline |
Caribou Biosciences |
Dynavax Technologies |
Caribou Biosciences and Dynavax Technologies Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Caribou Biosciences and Dynavax Technologies
The main advantage of trading using opposite Caribou Biosciences and Dynavax Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Dynavax Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will offset losses from the drop in Dynavax Technologies' long position.Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Dynavax Technologies vs. Fate Therapeutics | Dynavax Technologies vs. Caribou Biosciences | Dynavax Technologies vs. Arcus Biosciences | Dynavax Technologies vs. Karyopharm Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Fundamental Analysis View fundamental data based on most recent published financial statements |